Article
Mucosal Immune Response in BNT162b2 COVID-19 Vaccine Recipients
2021-06-29
Abstract excerpt
Background: Although the BNT162b2 COVID-19 vaccine is known to induce IgG neutralizing antibodies in serum protecting against COVID-19, it has not been studied in detail whether it could generate specific immunity at mucosal sites, which represent the primary route of entry of SARS-CoV-2. <br><br>Methods: Samples of serum and saliva of 60 BNT162b2-vaccinated healthcare workers were collected at baseline, two weeks...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 155b7adc-e36b-5d56-ac5d-8716db54b475
- DOI
- 10.2139/ssrn.3871718
